OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Forensic analysis of the 38 subject deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial
Corinne A. Michels, Daniel Perrier, Jeyanthi Kunadhasan, et al.
International Journal of Vaccine Theory Practice and Research (2023) Vol. 3, Iss. 1, pp. 973-1008
Open Access | Times Cited: 7
Corinne A. Michels, Daniel Perrier, Jeyanthi Kunadhasan, et al.
International Journal of Vaccine Theory Practice and Research (2023) Vol. 3, Iss. 1, pp. 973-1008
Open Access | Times Cited: 7
Showing 7 citing articles:
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
HEALING PROTOCOLS AND TOXICOLOGY TESTS FOR SEQUELAE OF COVID‑19 INJECTABLES
Ki-Yeob Jeon
International Journal of Research -GRANTHAALAYAH (2024) Vol. 12, Iss. 6
Closed Access
Ki-Yeob Jeon
International Journal of Research -GRANTHAALAYAH (2024) Vol. 12, Iss. 6
Closed Access
Considerations for improving future pandemic responses
Mikolaj Raszek, David E. Cowley, Rubio-Casillas Alberto
Journal of Vaccines and Immunology (2023) Vol. 10, Iss. 1, pp. 001-005
Open Access
Mikolaj Raszek, David E. Cowley, Rubio-Casillas Alberto
Journal of Vaccines and Immunology (2023) Vol. 10, Iss. 1, pp. 001-005
Open Access
